Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

India flag India · Delayed Price · Currency is INR
109.32
+1.76 (1.64%)
Mar 10, 2026, 11:14 AM IST
79.74%
Market Cap 2.24B
Revenue (ttm) 516.17M
Net Income (ttm) 6.52M
Shares Out 20.80M
EPS (ttm) 0.32
PE Ratio 342.92
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,075
Average Volume 34,176
Open 108.15
Previous Close 107.56
Day's Range 107.56 - 110.69
52-Week Range 55.30 - 147.00
Beta 0.50
RSI 41.29
Earnings Date Feb 11, 2026

About NSE:LOTUSEYE

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery t... [Read more]

Sector Healthcare
Founded 1989
Employees 348
Stock Exchange National Stock Exchange of India
Ticker Symbol LOTUSEYE
Full Company Profile

Financial Performance

In fiscal year 2025, NSE:LOTUSEYE's revenue was 495.63 million, an increase of 2.81% compared to the previous year's 482.10 million. Earnings were 7.39 million, a decrease of -74.63%.

Financial Statements

News

There is no news available yet.